Asclemed USA Recalls Lidolog Kit Lidocaine Injection Over Barcode Label Issue

Asclemed USA Inc. has voluntarily recalled 18 kits of ‘Lidolog Kit’ lidocaine HCL injection distributed within Tennessee after discovering that the outer label wrap covers the product barcode, making it difficult to scan at the point of use.

What Products Are Being Recalled?

The recalled product is the ‘Lidolog Kit,’ which contains Lidocaine HCL Injection, USP, 2% (2mL), packaged as a single dose for single use only. The product is Rx Only and carries NDC number 76420-760-01. It was distributed by Enovachem Pharmaceuticals of Torrance, CA 90501, and is being recalled by Asclemed USA Inc. The affected lot is 070126X1, with an expiration date of 12/31/2027. A total of 18 kits are included in this recall.

Why Was This Recall Issued?

The recall was initiated because the label wrap on the product packaging covers the barcode, which prevents pharmacy and healthcare staff from properly scanning the product. This has been classified under ‘Labeling: Not Elsewhere Classified’ by regulatory authorities. The issue has been designated a Class III recall, meaning the product is not likely to cause adverse health consequences, but the labeling defect could create tracking, verification, or dispensing errors if the barcode cannot be scanned correctly.

Who Is Affected?

This recall affects healthcare facilities and pharmacies within Tennessee that received the affected lot of the ‘Lidolog Kit.’ Because the product is Rx Only and used in clinical settings, individual consumers are unlikely to have purchased this item directly. However, patients who may receive lidocaine injections from an affected facility could be indirectly connected if barcode scanning issues lead to dispensing mix-ups.

What Should You Do?

Facilities and consignees holding lot 070126X1 of the ‘Lidolog Kit’ should stop using the affected product and set it aside. Contact Asclemed USA Inc. at their Torrance, CA offices for further instructions on returning or replacing the affected kits. Healthcare providers should verify lot numbers manually if barcode scanning is not possible, and report any related concerns to the FDA through the MedWatch Adverse Event Reporting program. Consumers who received an injection from an affected facility and have concerns should speak with their healthcare provider.

Official Statement

According to the recall record, this was a voluntary, firm-initiated recall with notification to consignees made via e-mail. No official press release has been issued for this recall. The recall was initiated on 7/15/2026, with a Center Classification Date of 7/20/2026, and the recall status remains ongoing with no termination date listed at this time.